Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Sungkyunkwan University
Seúl, Corea del SurPublications en collaboration avec des chercheurs de Sungkyunkwan University (2)
2016
-
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial
The Lancet, Vol. 387, Núm. 10027, pp. 1540-1550